Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2025-12-28 @ 9:19 AM
Study NCT ID:
NCT04556266
Status:
WITHDRAWN
Last Update Posted:
2025-05-13
First Post:
2020-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-15
First Submit QC Date:
None
Study First Post Date:
2020-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-08
Last Update Post Date:
2025-05-13
Last Update Post Date Type:
ACTUAL